benzylaminopurine has been researched along with olomoucine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanus, J; Havlícek, L; Leclerc, S; Meijer, L; Shaw, G; Strnad, M; Veselý, J | 1 |
| Cui, H; Fedoroff, NV | 1 |
| Krystof, V; Sipl, M; Trávnícek, Z | 1 |
3 other study(ies) available for benzylaminopurine and olomoucine
| Article | Year |
|---|---|
Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds.
Topics: Animals; CDC2 Protein Kinase; CDC28 Protein Kinase, S cerevisiae; Enzyme Inhibitors; Kinetin; Oocytes; Purines; Roscovitine; Starfish; Tumor Cells, Cultured | 1997 |
Inducible DNA demethylation mediated by the maize Suppressor-mutator transposon-encoded TnpA protein.
Topics: 2,4-Dichlorophenoxyacetic Acid; Adenine; Aphidicolin; Benzyl Compounds; Bromodeoxyuridine; Cell Division; Culture Techniques; Dexamethasone; DNA Methylation; DNA Replication; DNA-Binding Proteins; DNA, Plant; Gene Expression Regulation; Kinetin; Naphthaleneacetic Acids; Nicotiana; Plant Proteins; Plants, Genetically Modified; Purines; Repressor Proteins; Suppression, Genetic; Transcriptional Activation; Zea mays | 2002 |
Zinc(II) complexes with potent cyclin-dependent kinase inhibitors derived from 6-benzylaminopurine: synthesis, characterization, X-ray structures and biological activity.
Topics: Antineoplastic Agents; Benzyl Compounds; Cell Line, Tumor; Chlorides; Crystallography, X-Ray; Cyclin-Dependent Kinases; Differential Thermal Analysis; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Kinetin; Ligands; Magnetic Resonance Spectroscopy; Mass Spectrometry; Molecular Structure; Organometallic Compounds; Purines; Spectrophotometry, Infrared; Zinc Compounds | 2006 |